Two bacterial glycosphingolipid synthases responsible for the synthesis of glucuronosylceramide and α-galactosylceramide. [PDF]
Okino N +7 more
europepmc +1 more source
Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity. [PDF]
Wagner AK +9 more
europepmc +1 more source
Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1. [PDF]
Grabowska J +8 more
europepmc +1 more source
Invariant Natural Killer T Cell-Based Immunotherapy Using α-Galactosylceramide-Pulsed CD14<sup>+</sup> Monocytes for Advanced Gallbladder Cancer. [PDF]
Hanada K, Kobayashi K.
europepmc +1 more source
α-Galactosylceramide-expanded virtual memory CD8<sup>+</sup> T cells confer protection against a broad range of pathogens. [PDF]
Xie JX +6 more
europepmc +1 more source
α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice. [PDF]
Chen X +12 more
europepmc +1 more source
Identification of α-galactosylceramide as an endogenous mammalian antigen for iNKT cells. [PDF]
Hosono Y +12 more
europepmc +1 more source
Diphtheria Toxoid-Derived T-Helper Epitope and α-galactosylceramide Synergistically Enhance the Immunogenicity of Glycopeptide Antigen. [PDF]
Du JJ +9 more
europepmc +1 more source
Correction: Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer. [PDF]
Nagai H +5 more
europepmc +1 more source

